Correlation Between Adaptimmune Therapeutics and Leap Therapeutics
Can any of the company-specific risk be diversified away by investing in both Adaptimmune Therapeutics and Leap Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptimmune Therapeutics and Leap Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adaptimmune Therapeutics Plc and Leap Therapeutics, you can compare the effects of market volatilities on Adaptimmune Therapeutics and Leap Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptimmune Therapeutics with a short position of Leap Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptimmune Therapeutics and Leap Therapeutics.
Diversification Opportunities for Adaptimmune Therapeutics and Leap Therapeutics
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Adaptimmune and Leap is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Adaptimmune Therapeutics Plc and Leap Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Leap Therapeutics and Adaptimmune Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptimmune Therapeutics Plc are associated (or correlated) with Leap Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Leap Therapeutics has no effect on the direction of Adaptimmune Therapeutics i.e., Adaptimmune Therapeutics and Leap Therapeutics go up and down completely randomly.
Pair Corralation between Adaptimmune Therapeutics and Leap Therapeutics
Given the investment horizon of 90 days Adaptimmune Therapeutics Plc is expected to under-perform the Leap Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Adaptimmune Therapeutics Plc is 1.01 times less risky than Leap Therapeutics. The stock trades about -0.1 of its potential returns per unit of risk. The Leap Therapeutics is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest 306.00 in Leap Therapeutics on August 24, 2024 and sell it today you would lose (48.00) from holding Leap Therapeutics or give up 15.69% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Adaptimmune Therapeutics Plc vs. Leap Therapeutics
Performance |
| Timeline |
| Adaptimmune Therapeutics |
| Leap Therapeutics |
Adaptimmune Therapeutics and Leap Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adaptimmune Therapeutics and Leap Therapeutics
The main advantage of trading using opposite Adaptimmune Therapeutics and Leap Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptimmune Therapeutics position performs unexpectedly, Leap Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Leap Therapeutics will offset losses from the drop in Leap Therapeutics' long position.The idea behind Adaptimmune Therapeutics Plc and Leap Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Leap Therapeutics vs. X4 Pharmaceuticals | Leap Therapeutics vs. Terns Pharmaceuticals | Leap Therapeutics vs. Day One Biopharmaceuticals | Leap Therapeutics vs. PDS Biotechnology Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |